oxprenolol has been researched along with Cardiomegaly in 7 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
Excerpt | Relevance | Reference |
---|---|---|
"The effect of the beta-blocking agents propranolol and oxprenolol on isoproterenol-induced cardiac hypertrophy has been investigated in the rat." | 7.65 | Prevention of isoproterenol-induced cardiac hypertrophy by beta-blocking agents in the rat. ( Csáky, L; Nosztray, K; Szabó, J; Szegi, J, 1976) |
"The effect of the beta-blocking agents propranolol and oxprenolol on isoproterenol-induced cardiac hypertrophy has been investigated in the rat." | 3.65 | Prevention of isoproterenol-induced cardiac hypertrophy by beta-blocking agents in the rat. ( Csáky, L; Nosztray, K; Szabó, J; Szegi, J, 1976) |
"Oxprenolol treatment did not modify the blood pressure levels in the renal hypertensive rats nor in the spontaneously hypertensive turkeys." | 1.28 | Cardioprotection by beta-blockers: molecular and structural aspects in experimental hypertension. ( Dal Palù, C; Pauletto, P; Pessina, AC; Scannapieco, G; Vescovo, G, 1990) |
"To evaluate the effects of the chronic administration of the fixed combination slow-release, oxprenolol 160 mg and chlorthalidone 20 mg on left ventricular hypertrophy, ten hypertensive out-patients, with left ventricular hypertrophy documented by left ventricular mass index (LVMI) greater than 130 g/m2, were studied." | 1.27 | Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study. ( Alberti, D; Bertoni, T; De Ambroggi, L; Francucci, BM; Peloso, A, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Idikio, H | 1 |
Fernandez, PG | 1 |
Triggle, CR | 1 |
Kim, BK | 1 |
Petkov, O | 1 |
Szabó, J | 1 |
Nosztray, K | 1 |
Csáky, L | 1 |
Szegi, J | 1 |
Pauletto, P | 1 |
Vescovo, G | 1 |
Scannapieco, G | 1 |
Pessina, AC | 1 |
Dal Palù, C | 1 |
Sau, F | 2 |
Seguro, C | 2 |
Pili, G | 1 |
Basciu, M | 1 |
Siddi, PP | 1 |
Tamponi, R | 1 |
Cherchi, A | 2 |
Alberti, D | 2 |
Bertoni, T | 1 |
Peloso, A | 1 |
Francucci, BM | 1 |
De Ambroggi, L | 1 |
1 trial available for oxprenolol and Cardiomegaly
Article | Year |
---|---|
[Electrocardiographic and echocardiographic changes during antihypertensive therapy].
Topics: Acebutolol; Adolescent; Adult; Aged; Antihypertensive Agents; Captopril; Cardiomegaly; Chlorthalidon | 1990 |
6 other studies available for oxprenolol and Cardiomegaly
Article | Year |
---|---|
Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Heart Ventricles; Hydrochlorothiazide; Hypertens | 1983 |
Some functional changes in experimentally induced cardiac overload.
Topics: Aminooxyacetic Acid; Animals; Atropine; Cardiomegaly; Disease Models, Animal; Drug Combinations; Ele | 1983 |
Prevention of isoproterenol-induced cardiac hypertrophy by beta-blocking agents in the rat.
Topics: Animals; Cardiomegaly; DNA; Isoproterenol; Muscle Proteins; Myocardium; Oxprenolol; Propranolol; Rat | 1976 |
Cardioprotection by beta-blockers: molecular and structural aspects in experimental hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Blood Pressure; Calcium-Transporting ATPases; Cardiomeg | 1990 |
[Reduction of left ventricular hypertrophy and increased tolerance to exertion in hypertensive patients after antihypertensive therapy with slow-release oxprenolol and chlorthalidone].
Topics: Adult; Cardiomegaly; Chlorthalidone; Delayed-Action Preparations; Drug Therapy, Combination; Exercis | 1986 |
Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiomegaly; Chlorthalidone; Creatinine; Delayed-Action | 1988 |